Study on CancerSEEK Blood Test for Cancer Detection

Introduction to Cancer Detection Methods

A recent study published in the journal Science explores the effectiveness of CancerSEEK, a groundbreaking blood test designed to detect cancer at an early stage. Early detection is crucial, as tumors can often be treated successfully with surgical resection before they metastasize. However, once cancer spreads to other parts of the body, more aggressive treatments, such as chemotherapy and radiation, become necessary.

Limitations of Current Diagnostic Strategies

Current cancer diagnostic methods, including colonoscopies, mammograms, and cervical cytology, can be complex and invasive. To address these challenges, researchers in the United States are actively seeking innovative cancer diagnostic techniques that are quick, affordable, and effective.

Research Study Details

The study conducted by Cohen and colleagues involved a thorough investigation of CancerSEEK’s efficacy. It assessed the blood test’s ability to detect various cancers by measuring levels of eight proteins and 1,933 distinct mutations in cell-free DNA, which are typically elevated in cancer patients. The study included 812 healthy volunteers and 1,005 patients diagnosed with stage I to stage III cancers affecting the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, and breast. These cancers were selected due to their prevalence in Western populations and the absence of effective blood-based detection methods.

Results of the Study

The findings revealed that CancerSEEK produced positive results in the cancer patient group, achieving a median sensitivity of 70%. Sensitivity levels varied by cancer type, with a high of 98% in ovarian cancers and a low of 33% in breast cancers, indicating that the test’s effectiveness differs among cancer types. Additionally, the test demonstrated over 99% specificity, as only seven out of 812 healthy individuals were incorrectly identified as having cancer.

Using machine learning algorithms and data collected from CancerSEEK, the researchers successfully predicted the origin and type of cancer in the majority of the patients. Furthermore, they found that 90% of the mutations present in tumors from 153 patients were detectable at significant levels in their plasma samples.

Conclusion and Future Directions

In conclusion, the study established that CancerSEEK can effectively detect eight types of cancer with minimal false positives. This blood-based test is not intended to replace existing diagnostic strategies but serves as a convenient and cost-effective complementary tool. Further research with larger participant groups is necessary to validate these findings and explore CancerSEEK’s potential for detecting additional cancer types.

Author and Reference

Written by Haisam Shah, BSc
Reference: Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., … & Hruban, R. H. (2018). Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science, eaar3247.

Related Topics of Interest

– A New Blood Test for Endometriosis Detection
– Scientists Develop a New Blood Test for Multiple Myeloma
– Can a New System of Rapid Blood Tests for Heart Attack Improve Patient Care?
– Could a Blood Test for Concussion Help in Diagnosing Brain Injuries?
– Researchers Develop Blood Test to Diagnose Fibromyalgia
– A Simple Blood Test May Soon Be Able to Predict Preterm Birth